Unnamed combination immunotherapy

· Shenzhen Geno-Immune Medical Institute

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Unnamed combination immunotherapy, covering 2025-09-09 to 2025-09-09. Get the full timeline:

Most recent: Clinical Trial Update: Combination Immunotherapy Targeting Melanoma [Phase 1, Phase 2]